Why the study?
The study was conducted to evaluate the prognostic value of LV GLS and LVMD in patients with ischemic and nonischemic cardiomyopathy.
Does the assessment of left ventricular global longitudinal strain and mechanical dispersion by speckle tracking echocardiography predict ventricular arrhythmias and MACE in patients with ischemic and nonischemic cardiomyopathy?
Does the assessment of left ventricular global longitudinal strain and mechanical dispersion by speckle tracking echocardiography predict ventricular arrhythmias and MACE in patients with ischemic and nonischemic cardiomyopathy?
Left ventricular global longitudinal strain and mechanical dispersion assessed by speckle tracking echocardiography provide significant prognostic value for predicting ventricular arrhythmias and MACE in patients with ischemic and nonischemic cardiomyopathy.
LV GLS and LVMD support VA and MACE risk stratification in cardiomyopathy; extends observational data but requires prospective validation before practice change.
Aim. To conduct a systematic review and meta-analysis in order to evaluate the prognostic value of left ventricular global longitudinal strain (LV GLS) and LV mechanical dispersion (LVMD) in ischemic and nonischemic cardiomyopathy. Material and methods . We searched PubMed, Google Scholar and Embase for studies on the prognostic value of LV GLS and LVMD in ischemic and nonischemic cardiomyopathy. Hazard ratios (HR) from included studies were pooled for metaanalysis. Results. Twelve studies were selected from 314 publications for this systematic review and meta-analysis. In total, 2624 patients (mean age, 57,3 years; mean follow-up, 40,8 months) were included in the analysis. Meta-analysis showed that decreased LV GLS was associated with an increased risk of ventricular arrhythmias (VAs) (adjusted HR: 1,10 per 1% of GLS; 95% CI: 1,01-1,19; p=0,03) and major adverse cardiovascular events (MACE): adjusted HR: 1,22 per 1% of GLS; 95% CI: 1,11-1,33; p<0,0001). Patients with VAs had greater LVMD than those without it (weighted mean difference, 33,69 ms; 95% CI: -41,32 to -26,05; p<0,0001). Each 10 ms increment of LVMD was significantly and independently associated with VA episodes (adjusted HR: 1,18; 95% CI: 1,08-1,29; p=0,0002). Conclusions. LV GLS and LVMD assessed using speckle tracking provides important predictive value and can be used as an effective tool for stratifying risk in patients with ischemic and nonischemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Голухова et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: